Stocks / NYSE / Arcus Biosciences, Inc.

Arcus Biosciences, Inc.

Our Opinion

Arcus Biosciences, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for medical analysis and clinical research purpose.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“Data demonstrated that AB122 is similar to nivolumab in terms of binding affinity, selectivity and anti-tumor activity in an animal model.” Read the following article

Company Description

Company Website: